Survival of immunobiological drugs in psoriasis : preliminary data from a tertiary hospital experience in Southern Brazil
dc.contributor.author | Lima, Elis Costa de | pt_BR |
dc.contributor.author | Boza, Juliana Catucci | pt_BR |
dc.contributor.author | Palominos, Penelope Esther | pt_BR |
dc.contributor.author | Xavier, Ricardo Machado | pt_BR |
dc.contributor.author | Cestari, Tania Ferreira | pt_BR |
dc.date.accessioned | 2022-07-28T04:44:41Z | pt_BR |
dc.date.issued | 2021 | pt_BR |
dc.identifier.issn | 0365-0596 | pt_BR |
dc.identifier.uri | http://hdl.handle.net/10183/245577 | pt_BR |
dc.format.mimetype | application/pdf | pt_BR |
dc.language.iso | eng | pt_BR |
dc.relation.ispartof | Anais brasileiros de dermatologia. Rio de Janeiro. Vol. 96, n. 3 (2021), p. 376-379. | pt_BR |
dc.rights | Open Access | en |
dc.subject | Psoríase | pt_BR |
dc.subject | Tratamento farmacológico | pt_BR |
dc.subject | Sobrevida | pt_BR |
dc.title | Survival of immunobiological drugs in psoriasis : preliminary data from a tertiary hospital experience in Southern Brazil | pt_BR |
dc.type | Artigo de periódico | pt_BR |
dc.identifier.nrb | 001146347 | pt_BR |
dc.type.origin | Nacional | pt_BR |
Este item está licenciado na Creative Commons License
-
Artigos de Periódicos (41045)Ciências da Saúde (10989)